Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS ClinicalTrials.gov record with results posted

Multicentre, Open-label Phase 2 Trial Evaluating the Efficacy of CARBOPLATIN in Metastatic Prostate Cancer With Gene Alterations in the Homologous Recombination Pathway

This page presents selected fields from the linked source record. It does not add a medical interpretation.

Open original source record ↗

Record identity and dates

Source
ClinicalTrials.gov
Source record ID
NCT03652493
Title field or adapter rule
protocolSection.identificationModule.officialTitle
Ingested At
2026-06-12T00:05:56.034896+00:00
Published At
2026-06-11T00:00:00+00:00
Record Updated At
2026-06-11
Results Posted At
2026-06-11
Timestamp Basis
source retrieval time was not retained by the feed adapter
Date limitation
source retrieval time was not retained by the feed adapter

Fields recorded by this source

protocolSection.conditionsModule.conditions
["Castration-resistant Prostate Cancer", "Metastasis"]
protocolSection.statusModule.lastUpdatePostDateStruct.date
"2026-06-11"
protocolSection.identificationModule.nctId
"NCT03652493"
protocolSection.identificationModule.officialTitle
"Multicentre, Open-label Phase 2 Trial Evaluating the Efficacy of CARBOPLATIN in Metastatic Prostate Cancer With Gene Alterations in the Homologous Recombination Pathway"
protocolSection.statusModule.overallStatus
"COMPLETED"
protocolSection.designModule.phases
["PHASE2"]
protocolSection.statusModule.resultsFirstPostDateStruct.date
"2026-06-11"

Study condition terms

  • Castration-resistant Prostate Cancer (protocolSection.conditionsModule.conditions)
  • Metastasis (protocolSection.conditionsModule.conditions)

Intervention details are not present in the imported fields for this record. No drug-condition relationship is inferred from co-listing.

This index keeps the source fields it imported; it may not contain the complete original record. Verify wording and context in the linked source.